Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Hyperreflexia of Bladder”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Large-scale testing (Phase 3)Study completedNCT02501928
What this trial is testing

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 12
Testing effectiveness (Phase 2)Ended earlyNCT00712322
What this trial is testing

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Warner Chilcott 35
Not applicableStudy completedNCT01629433
What this trial is testing

Onabotulinumtoxina Intradetrusorial Injections and NGF Expression

Who this might be right for
Overactive DetrusorDetrusor Hyperreflexia of Bladder
University Of Perugia 25
Testing effectiveness (Phase 2)Study completedNCT00583219
What this trial is testing

Botulin-A Toxin Instillations and Overactive Bladder

Who this might be right for
Overactive BladderDetrusor InstabilityDetrusor Hyperreflexia
Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Large-scale testing (Phase 3)Study completedNCT02849418
What this trial is testing

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Who this might be right for
Urinary Bladder, Overactive
GlaxoSmithKline 21
Large-scale testing (Phase 3)Ended earlyNCT02660359
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 258
Not applicableStudy completedNCT05504200
What this trial is testing

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Who this might be right for
Spinal Cord Injuries
RNOH RIC 15
Not applicableStudy completedNCT01297660
What this trial is testing

Neuro-urological Outcome After Spinal Cord Injury

Who this might be right for
Urinary Bladder Neurogenic Dysfunction
Balgrist University Hospital 55
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Not applicableStudy completedNCT02590250
What this trial is testing

A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 250
Large-scale testing (Phase 3)Active Not RecruitingNCT05621616
What this trial is testing

Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Global Development, Inc. 7
Testing effectiveness (Phase 2)UnknownNCT03187795
What this trial is testing

Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesUrinary Bladder, Neurogenic
Kessler Foundation 62
Post-approval studies (Phase 4)Study completedNCT02601287
What this trial is testing

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 168
Not applicableStudy completedNCT01477736
What this trial is testing

A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity

Who this might be right for
Spinal Cord Injury
Centro de Reabilitação e Readaptação Dr. Henrique Santillo 68
Not applicableStudy completedNCT01226706
What this trial is testing

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Who this might be right for
Urinary Urge Incontinence
Saskatchewan Health Authority - Regina Area 21
Not applicableWithdrawnNCT01043848
What this trial is testing

Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients

Who this might be right for
Neurogenic Detrusor OveractivitySpinal Cord Injury
Ulrich Mehnert
Large-scale testing (Phase 3)Study completedNCT01600716
What this trial is testing

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Who this might be right for
Urinary IncontinenceMultiple SclerosisNeurogenic Bladder
Allergan 144
Early research (Phase 1)Study completedNCT02211846
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Who this might be right for
Neurogenic Detrusor OveractivityOveractive BladderPharmacokinetics of Mirabegron
Astellas Pharma Inc 34
Testing effectiveness (Phase 2)Ended earlyNCT00845338
What this trial is testing

Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity

Who this might be right for
Multiple SclerosisOveractive Detrusor
Bayer 7
Load More Results